Disclaimer

The Australasian Society of Clinical Immunology and Allergy (ASCIA) is the peak professional body of clinical immunology and allergy specialists in Australia and New Zealand.

The content of ASCIA primary immunodeficiency (PID) e-training for health professionals (HP) has been reviewed by ASCIA members, represents the available published literature at the time of review and is not intended to replace professional medical advice. Any questions regarding a medical diagnosis or treatment should be directed to a medical practitioner.

ASCIA PID e-training HP has been developed to provide ready access to reliable and consistent primary immunodeficiency education for all health professionals throughout Australia and New Zealand, at no charge. Initial funding for development of ASCIA PID e-training HP has been obtained from CSL Behring and Shire Australia. ASCIA will retain copyright and control over content of ASCIA PID e-training HP, and update it as evidence based changes occur in the medical literature.

Whilst a Certificate of Completion for ASCIA PID e-training HP can be provided as proof that training has been successfully completed, the certificate is not a qualification as ASCIA is not an accrediting body. ASCIA PID e-training HP is not a PID train the trainer course.

ASCIA PID e-training HP contains links to other websites. These linked websites are not under the control of ASCIA and inclusion of any link does not imply endorsement of the linked website by ASCIA.

Any inquiries regarding ASCIA PID e-training HP should be emailed to  projects@allergy.org.au

Due to the potential number of inquiries a contact telephone number is not available.

Last modified: Wednesday, 2 March 2016, 11:09 PM